Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > Open 5.18 high 5.47 and low 4.17

<< Previous

Bullboard Posts

Next >>

Comment by Polaris570on Dec 16, 2020 1:07am

303 Views

Post# 32116305

RE:RE:RE:Open 5.18 high 5.47 and low 4.17

Like I said also obviously it depends on what your entry is. And second of all your full of shi$ with your position at .050$. You should of used a uneven number fifty is too obviuos. You probably went fomo and your probably in the red now. You bullshi$ your friends I will bullshi$ my friends but lets not bullshit each other. GLTA

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland